Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00028901
DRKS00028901
Recruiting
Not Applicable

Evaluation of imaging biomarkers and longitudinal assessment of global and regional cardiac function by cardiac MRI during recovery from COVID-19 infection in a multicenter normalized cohort - NAHAP-KAM

Klinikum der Universität München, Campus Großhadern0 sites150 target enrollmentJune 30, 2022
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsZ03.8Observation for other suspected diseases and conditions

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Z03.8
Sponsor
Klinikum der Universität München, Campus Großhadern
Enrollment
150
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 30, 2022
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Klinikum der Universität München, Campus Großhadern

Eligibility Criteria

Inclusion Criteria

  • •All patients (age: \>18 years, no gender or ethnicity restrictions) who underwent one or more cardiac MRI examination(s) as a result of detected COVID\-19 acquisition (PCR test) in the NAPKON HAP cohort will be included in the analysis.

Exclusion Criteria

  • •\- Patients without an existing cardio\-MRI examination.
  • •\- Lack of evidence of COVID\-19 disease.
  • •\- Contraindication to MR imaging (metal, renal insufficiency, lack of compliance)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
The methods of clinical assessments for non-alcoholic fatty liver diseaseEndocrine, nutritional and metabolic disease
KCT0003144Gachon University Gil Medical Center75
Recruiting
Not Applicable
Analysis of imaging biomarkers in development and growth of geographic atrophy in Japanese with dry aged macular degeneratiodry age-related macular degeneration
JPRN-UMIN000050605Jichi Medical University40
Recruiting
Not Applicable
A non-randomised study investigating the use and timing of multiparametric magnetic resonance imaging (mpMRI) and positron emission tomography (PET) to develop imaging biomarkers that will be used to predict treatment response following radiotherapy for prostate cancer treatment.
ACTRN12618001810202niversity of Sydney30
Recruiting
Not Applicable
Prognostic value of imaging biomarkers in patients with hepatocellular carcinoma treated with liver TransplantatioC22.0Liver cell carcinoma
DRKS00027969MU München200
Recruiting
Not Applicable
Investigation of clinical biomarkers reflecting the neurological basis of depressive symptoms and their usefulness in novel therapeutic techniquedepressive symptoms
JPRN-UMIN000026411Gunma University210